MHG
Orchestrated approach to drug development with a 'Time to Value' focus
MHG
Orchestrated approach to drug development with a 'Time to Value' focus
Orchestrated approach to drug development with a time to value focus.
Embracing multi-disciplinary teams, repurposing, repositioning, and partnerships for accelerated outcomes.
Our investment models include both DEFI/Deci structures as well as traditional investment models. We establish empowered, and enabled SPVs with therapeutic focus: dermatology, oncology, neurology, ophthalmology.
Our Partners
